wellwoman

Free Webinar On Treatment Of Fibroids

Filed in archive Menopause , Pregnancy , Sexual Health on June 16, 2010

What: Free Webinar On The Latest In Treating Fibroids

When: Saturday, June 19, 2010 at 10 am PST

Interested on the latest about fibroids? Then join a free live webinar about fibroids and treatment options.

The said webinar will last for about an hour and UCLA professor Bruce McLucas, M.D. will cover fibroids in detail (including menopause and fibroids, pregnancy and fibroids, surgical and non-surgical treatments such as uterine artery embolization) and many other topics relating to fibroids.

Dr. McLucas is the founder of Los Angeles-based Fibroid Treatment Collective and an expert on fibroids.

For more information and to register for the webinar, visit Fibroid Treatment Collective or call 1.866.362.6463. You can also follow Dr. McLucas on Twitter @fibroiddoctor or become a Facebook fan.

Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

Ella Works Longer Than 'Morning After' Pill

Filed in archive Birth Control , Sexual Health on June 14, 2010

Ella Works Longer Than 'Morning After' Pill
© meddygarnet
Already available in the European market - Ella (ulipristal acetate)- which works a lot longer than the US's 'morning after' pill is pending approval in the United States.

Manufactured by a French drug company, Ella works as long as five days after unprotected sex. The ''morning after' pill or Plan B on the other hand works only up to 72 hours after unprotected sex. Ella then sounds too good to be true right? But then the drug is a close chemical relative of the abortion pill RU-486.

So there's where the debate starts. The pending approval of Ella in the US has sparked attention form every corner of the country. While advocates of family planning and reproductive rights in the US are welcoming the new drug Ella, their opponents are saying that Ella could also induce abortion and it could be misleading if FDA label it as an emergency contraceptive drug.

Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

The Bill & Melinda Gates Foundation: To Focus on Maternal and Child Health

Filed in archive Child Health , Maternal Health on June 8, 2010

The Bill & Melinda Gates Foundation: To Focus on Maternal and Child Health
© Space Ritual
Previously focusing on infectious diseases, vaccines and HIV and AIDS, the Bill and Melinda Gates Foundation said it would spend $1.5 billion over the next five years on maternal and child health, family planning and nutrition programs in developing countries, emphasizing the foundation's new health focus.

In developing countries, pregnancy and child birth often end in a tragic death. Mainly due to lack of education, health experts and clean supplies needed for pregnancy and childbirth. This problem however can be solved at cheaper rates. Such is the premise on the new focus of the Bill & Melinda Gates Foundation.

In a speech on Monday in a conference in Washington DC, Melinda Gates said:

"Pregnancy and childbirth often "end in tragedy" in poor countries, but that most of the deaths could be prevented at a "stunningly" low cost. The world must come together to save women's and children's lives."

Melinda Gates said that much of the next $1.5 billion would go to programs in India, Ethiopia and other countries where mothers and children have relatively high death rates.

Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

Skin Cancer and Sun Protection

Filed in archive Lifestyles , Skin Cancer on June 1, 2010

Skin Cancer and Sun Protection
© m00by
Summer is here at last and we should not forget the importance of sun protection.

Here are a few misconceptions about sun protection:

1. A T-shirt can replace sunscreen during a day in the sun. A typical T-shirt is equivalent to Sun Protection Factor (SPF) 10, and a polo shirt is only slightly better. But then, who want to wear a polo shirt when frolicking on the beach this summer?

2. SPF determines the level of coverage that sunscreen provides. Make sure the sunscreen protects from both UVA and UVB rays and contains a physical block such as titanium oxide or zinc oxide.

3. Sun protection is not necessary with overcast skies or time spent in the shade. But ultraviolet light can penetrate cloud coverage and cause skin damage.

According to Dr. Peter Lee, director of the Dermatologic Surgery and Laser Center and professor of dermatology at the University of Minnesota Medical School: The best way to avoid skin cancer is to wear sun block with a broad spectrum of protection. Be sure to re-apply several times throughout the day, and when possible, take breaks in the shade if out in the sun for an extended period of time. It is important to get suspicious moles and lesions checked out immediately to ensure early and successful treatment.

So have fun under the sun this summer but don't forget to put on your sunscreen lotion before going out!

Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo

Female Viagra May Get FDA's Approval

Filed in archive Sexual Health on May 24, 2010

Female Viagra May Get FDA's Approval
© Lars Plougmann
The US FDA advisory panel will consider whether to approve a drug that will increase the sexual libido of women with hypoactive sexual desire disorder (HSDD). The drug called flibanserin was developed by Boehringer Ingelheim.

Flibanserin, first developed as an antidepressant works by reducing serotonin levels in the brain thereby reducing signals from areas of the brain that inhibit feeling desire.

According to Boehringer Ingelheim: "women deserve options and we're hoping flibanserin may represent a safe and effective option for many women."

Flibanserin (dubbed as pink Viagra) increases the sexual libido in women as does Viagra in men. Trials conducted by the manufacturer resulted in an increase in satisfying sexual activity in women with HSDD. However, there were no mention about other side effects.

Bookmark
img Addthis
img Ask
img Blinklist
img del.icio.us
img Digg
img Fark
img Facebook
img Google
img Lycos
img Ma.gnolia
Add this page to Mister Wong Mr Wong
img Netscape
img Netvousz
img Newsvine
img Reddit
img StumbleUpon
img Slashdot
img Tailrank
img Technorati
img Wink
img Yahoo
Share It
RSSrss
Google google
Yahoo! yahoo
Addthis Subscribe using any feed reader!
Bloglines Bloglines
TwitterFollow us on Twitter!
Most Popular   Accidents   Arthritis   Beauty   Best of   Birth Control   Bone Health   Breast Cancer   Cancer, General   CFS and Fibromyalgia   Child Health   Diabetes   Did you know   Diet and Food   Digestive Health   Exercise   Eye Health   General Health   Heart and Stroke   Infertility   Information about